Building a Collaborative Informatics Platform for Translational Research: Prof. Yike Guo Department of Computing Imperial College London
|
|
|
- Abner Nichols
- 10 years ago
- Views:
Transcription
1 Building a Collaborative Informatics Platform for Translational Research: An IMI Project Experience Prof. Yike Guo Department of Computing Imperial College London
2 Living in the Era of BIG Big Data : Massive amounts of information derived from dry /wet lab investigations, feasibility studies and clinical trials. Big Science: Research silos are evaporating with the merging of scientific methods. Traditional hypothesis-testing studies will couple with data-driven research. Big Collaboration : As evidence accumulates, personalized medicine will become a reality, and patient-specific cancer interventions will become available. Teams of disease specialists, researchers and bioinformaticiansworking in concert in a virtual frontier.
3 Collaboration Platform is the Key for Doing Big Science with Big Data
4 New Science Economy Model: Public-Private Partnership forresearch
5 The Requirements for PPP-based Translational Research IT Infrastructure : hosted and shared by a community Data management: shared with configurable access control by various subgroups of a community Software : PaaSfor development community Analysis : collaborative analysis Knowledge management: Dynamic integration of knowledge based on semantics
6 PPP Example : EU IMI
7 U-BIOPRED Project: An IMI Project Innovative Medicines Imitative (IMI) Worlds largest public private partnership 2 Billion Euro: 1 Billion from EU, 1 Billion from EFPIA U-BIOPRED: Unbiased Biomarkers for predicting respiratory disease outcomes 40 Party Collaboration between 10 Pharma& 30 Academic Medical Centres Knowledge Management Work Package Imperial Data Co-ordinator, JnJ TranSMART AZ, Roche, UCB, CNRS
8 UBIOPRED Knowledge Product : Handprints 1. Reaching international consensus on diagnostic criteria 2. Creating adult/pediatriccohorts and biobanks 3. Creating novel biology handprints by combining molecular, histological, clinical and patient-reported data 4. Validating such handprints in relation to exacerbations and disease progression 5. Refining the handprints by using preclinical and human exacerbation models 6. Predicting efficacy of gold-standard and novel interventions 7. Refining the diagnostic criteria and phenotypes 8. Establishing a platform for exchange, eduction and dissemination
9 A Typical Querying Process Query e.g. age Sub-set of «X» matched patient Specific «Y» criteria e.g. diagnostic Sub-set of patients «Z» measurements originating from different partners e.g. proteomics Integrated analysis methods 3 pathways Omics Data export to analysis tool Export Omicsdata-matrix and context to tab. files Search for connection to inflammation regulating drugs Query for disease association Create own pathway Upload exported files into Application (cloud/systems) Perform analysis Export analytsis results into KR Use public and proprietary omics data to infer network extensions and connect disjunct networks Select patients which provided sample associated the results and check their physiologic data for significant differences.
10 The Challenge in Building the KM for UBIOPRED The consortium formed as a loosely coupled virtual organisation Such a VO conducts highly collaborative and multidisciplinary scientific activities Data is generated by many people in the VO with a wide range of connected modalities Knowledge is build through an iterative knowledge production process where data need to be incrementally collected, flexibly integrated, systematically analysed and interactively reported Project has a period but knowledge need to be managed forever Very big task with very little money
11 U-BIOPRED KM System Design Goal and KM Key Features Cohort-based information integration to support clinical driven integrative biomarker study Cloud based infrastructure to facilitate collaborative translational research An integrated framework supports the management of a collaborative knowledge production process (curation, analysis, content enhancement, reporting, modeling and simulation) A sustainable environment with longevity and total ownership : workflow-based PaaS for integrative analytics: CurationETL workbenches Analytics workbenches A scalable platform adaptable for future science/technology development (such as NGS technology; medical image et.al )
12 UBIOPRED Collaborative TR Platform Analytical Register : Research Collaboration Management TranSMART: Cohort-based Omics Data Management IDBS InforSense Workflow: Analytical Engine + Development PaaS TSmart DB Sample Tracking Gene Pattern&R Analytical Registry EWB for Assay Data Management InforSense KDE Workflow Virtual Machines IC Cloud (Virtualisation Layer) Physical Layer (Imperial Based Data Centre) 30/04/2012 Deploying TranSmart to UBIOPRED 12
13 UBIOPRED TR Platform Components Content Building: Curation (ETL/Ontology) Omics Experiment Management (ELN/LIMS) Collaborative Study Management (Collaboration Management) System Biology Study (Modelling and Simulation) UBIOPRED TR Platform Study Data Management (transmart) Biomarker Data Analysis (Analytical Workflow)
14 Curation: Building Study Contents and Background Knowledge transmart-based UBIOPRED Study Data Management System
15 OmicsExperiment Management Omicsexperiments (Proteomics, lipidomics experiments (WP7) and pre-clinical study (WP6) are managed with EWB of IDBS
16 Study Data Management Study oriented curated data together with patient information are integrated and warehoused in transmartfor analysis (WP8) From John Shonet.al transmart, AMIA TBI 2012
17 Coefficient of variation test Statistical tests (e.g., KS test, permutation test) Workflow-based Analytics: A Proteomics Example Q-TOF mass spectrometry experiment Mass Spectra MS MS data preprocessing m/z peak data Peak Selection Selected peaks Intensity Calibration Baseline Correction Noise Reduction and Smoothing Peak Detection Peak Alignment Use Monte Carlo method to randomly select other biomarker detection models and alternative parameter settings Intensity 0 Smoothed MS Peaks Smoothed MS Peaks m/z Intensity Normalizationm/z Cross-validation CV training set CV testing set Supervised learning (e.g., SVM, discriminant analysis) Classification model Label prediction Model performance
18 Workflows in InforSense
19 Workflow Deployed as Cloud Applications Cloud Scientist Develop, Deploy and Share Experiments on Cloud Experiment Experiment Experiment Scientist Consume Experiments on Cloud Experiment Deployment Elastic Scheduler OS VM OS VM OS VM Develop, Deploy and Share Experiments on Cloud Hypervisor Physical Infrastructure Scientist Scientist
20 A Development Cycle of Cloud Application Building via Workflow
21 Analytical Register: Enables Collaborative Knowledge Management
22 Mapping Research Collaboration in UBIOPRED UBIOPRED Work Package Cohort Investigation Procedure Researcher Study Organisation
23 Analytical Register: A Study View
24 Analytical Register: Work Package View
25 Analytical Register: A Cohort View
26 Analytical Register: Interfacing to Cohort Selection
27 Analytical Register Cohort View
28 Analytical Register: An Investigation View
29 Analytical Register: Investigation Drill Down
30 Analytical Register Further Drill Down: Method
31 Analytical Register: Interfacing to Sample Tracking
32 Analytical Register: Fully Integrated with TranSMART
33 UBIOPRED System Biology Study 1. We have developed p38 pathway model in SBML and perform simulation throughput MATLAB.
34 UBIOPRED System Biology Study 2. We have proposed a novel glucocorticoid signalling pathway model in SBML.
35 UBIOPRED System Biology Study 3. We have proposed some hypotheses to suggest possible crosstalk between GC and p38 pathways. 4. We then construct the integrated pathway model in SBML. 5. Test the stability of this integrated model.
36 Extending UBIOPRED to Support Multiple Projects Project 1 Project n Virtual Container DB Instance Virtual Container Virtual Container Virtual Container DB Instance DB Instance DB Instance
37 etriks: European translational research and knowledge management services
38 Conclusion: the end of the begining UBIOPRED knowledge management system supports cross-institutional large scale translational research UBIOPRED knowledge management system support the entire knowledge production process For PPP-based TR projects, collaborative research support in a VO environment is circuital Modern technology such as cloud and workflow provide the technical foundation for its implementation The development is moving forward to support IMI translational projects in general by etriksproject
A leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
Dr Alexander Henzing
Horizon 2020 Health, Demographic Change & Wellbeing EU funding, research and collaboration opportunities for 2016/17 Innovate UK funding opportunities in omics, bridging health and life sciences Dr Alexander
Euro-BioImaging European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences
Euro-BioImaging European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences WP11 Data Storage and Analysis Task 11.1 Coordination Deliverable 11.2 Community Needs of
Find the signal in the noise
Find the signal in the noise Electronic Health Records: The challenge The adoption of Electronic Health Records (EHRs) in the USA is rapidly increasing, due to the Health Information Technology and Clinical
MultiQuant Software 2.0 for Targeted Protein / Peptide Quantification
MultiQuant Software 2.0 for Targeted Protein / Peptide Quantification Gold Standard for Quantitative Data Processing Because of the sensitivity, selectivity, speed and throughput at which MRM assays can
An EVIDENCE-ENHANCED HEALTHCARE ECOSYSTEM for Cancer: I/T perspectives
An EVIDENCE-ENHANCED HEALTHCARE ECOSYSTEM for Cancer: I/T perspectives Chalapathy Neti, Ph.D. Associate Director, Healthcare Transformation, Shahram Ebadollahi, Ph.D. Research Staff Memeber IBM Research,
The Evolution of Data Platforms in IMI. Anthony Rowe, Janssen R&D IT 08 April 2016 Med-e-Tel Luxembourg
The Evolution of Data Platforms in IMI Anthony Rowe, Janssen R&D IT 08 April 2016 Med-e-Tel Luxembourg Three trends in technology today Ubiquity of the Internet Three trends in technology today Ubiquity
ORACLE HEALTH SCIENCES INFORM ADVANCED MOLECULAR ANALYTICS
ORACLE HEALTH SCIENCES INFORM ADVANCED MOLECULAR ANALYTICS INCORPORATE GENOMIC DATA INTO CLINICAL R&D KEY BENEFITS Enable more targeted, biomarker-driven clinical trials Improves efficiencies, compressing
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE CRUK Stratified Medicine Initiative Somatic mutation testing for prediction of treatment response in patients with solid tumours:
AGILENT S BIOINFORMATICS ANALYSIS SOFTWARE
ACCELERATING PROGRESS IS IN OUR GENES AGILENT S BIOINFORMATICS ANALYSIS SOFTWARE GENESPRING GENE EXPRESSION (GX) MASS PROFILER PROFESSIONAL (MPP) PATHWAY ARCHITECT (PA) See Deeper. Reach Further. BIOINFORMATICS
Integrated Biomedical and Clinical Research Informatics for Translational Medicine and Therapeutics
Integrated Biomedical and Clinical Research Informatics for Translational Medicine and Therapeutics J. Richard Landis, PhD Robert M. Curley, MS Gregg Fromell, MD Center for Clinical Epidemiology and Biostatistics
Teaching Computational Thinking using Cloud Computing: By A/P Tan Tin Wee
Teaching Computational Thinking using Cloud Computing: By A/P Tan Tin Wee Technology in Pedagogy, No. 8, April 2012 Written by Kiruthika Ragupathi ([email protected]) Computational thinking is an emerging
Leading Genomics. Diagnostic. Discove. Collab. harma. Shanghai Cambridge, MA Reykjavik
Leading Genomics Diagnostic harma Discove Collab Shanghai Cambridge, MA Reykjavik Global leadership for using the genome to create better medicine WuXi NextCODE provides a uniquely proven and integrated
The Scheduled MRM Algorithm Enables Intelligent Use of Retention Time During Multiple Reaction Monitoring
The Scheduled MRM Algorithm Enables Intelligent Use of Retention Time During Multiple Reaction Monitoring Delivering up to 2500 MRM Transitions per LC Run Christie Hunter 1, Brigitte Simons 2 1 AB SCIEX,
Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research
Anforderungen der Life-Science Industrie an die Hochschulen Hans Widmer Novartis Institutes for BioMedical Research There s nothing more extraordinary than a normal life 2 What does industry expect from
Preparing the scenario for the use of patient s genome sequences in clinic. Joaquín Dopazo
Preparing the scenario for the use of patient s genome sequences in clinic Joaquín Dopazo Computational Medicine Institute, Centro de Investigación Príncipe Felipe (CIPF), Functional Genomics Node, (INB),
BIOBANK QUALITY. [email protected] Office: 602-546-1285
BIOBANK QUALITY David F Carpentieri, M.D. Pediatric Pathologist and Biorepository Director, Phoenix Children s Hospital Assistant Professor of Pediatrics and Clinical Pathology, University of Arizona Assistant
Big Data An Opportunity or a Distraction? Signal or Noise?
Big Data An Opportunity or a Distraction? Signal or Noise? Maya R. Said, Sc.D. SVP & Global Head, Oncology Policy & Market Access, Novartis 3rd International Systems Biomedicine Symposium Luxembourg, 28
Big Data Trends A Basis for Personalized Medicine
Big Data Trends A Basis for Personalized Medicine Dr. Hellmuth Broda, Principal Technology Architect emedikation: Verordnung, Support Prozesse & Logistik 5. Juni, 2013, Inselspital Bern Over 150,000 Employees
Matteo di Tommaso FDA-PhUSE March 2013 Vice President, Research Business Technology Chair, PRISME Forum
Pharma R&D IT & The Cloud Matteo di Tommaso FDA-PhUSE March 2013 Vice President, Research Business Technology Chair, PRISME Forum This presentation outlines a general technology direction. Pfizer Inc has
Running Agilent GeneSpring MPP on the Cloud
Running Agilent GeneSpring MPP on the Cloud Technical Overview Authors Stephen Madden, Rick A. Fasani, and Michael Rosenberg Agilent Technologies, Inc. Santa Clara, California, USA Introduction Cloud computing
Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences
Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences It s not information overload, it s filter failure. Clay Shirky Life Sciences organizations face the challenge
BIOINF 525 Winter 2016 Foundations of Bioinformatics and Systems Biology http://tinyurl.com/bioinf525-w16
Course Director: Dr. Barry Grant (DCM&B, [email protected]) Description: This is a three module course covering (1) Foundations of Bioinformatics, (2) Statistics in Bioinformatics, and (3) Systems
Preprocessing, Management, and Analysis of Mass Spectrometry Proteomics Data
Preprocessing, Management, and Analysis of Mass Spectrometry Proteomics Data M. Cannataro, P. H. Guzzi, T. Mazza, and P. Veltri Università Magna Græcia di Catanzaro, Italy 1 Introduction Mass Spectrometry
Statistical Analysis. NBAF-B Metabolomics Masterclass. Mark Viant
Statistical Analysis NBAF-B Metabolomics Masterclass Mark Viant 1. Introduction 2. Univariate analysis Overview of lecture 3. Unsupervised multivariate analysis Principal components analysis (PCA) Interpreting
BIOINF 585 Fall 2015 Machine Learning for Systems Biology & Clinical Informatics http://www.ccmb.med.umich.edu/node/1376
Course Director: Dr. Kayvan Najarian (DCM&B, [email protected]) Lectures: Labs: Mondays and Wednesdays 9:00 AM -10:30 AM Rm. 2065 Palmer Commons Bldg. Wednesdays 10:30 AM 11:30 AM (alternate weeks) Rm.
What s New in Pathway Studio Web 11.1
1 1 What s New in Pathway Studio Web 11.1 Elseiver is pleased to announce the release of Pathway Studio Web 11.1 for all database subscriptions (Mammal, Mammal+ChemEffect+DiseaseFx, Plant). This release
Analyzing NGS data with clinical data: open source software for translational medicine
Analyzing NGS data with clinical data: open source software for translational medicine BASEL LIFE SCIENCE WEEK NGS FORUM SEPTEMBER 24, 2015 Kees van Bochove, CEO The Hyve Agenda 1. Introduction 2. Open
Enabling Technologies for Collaborative Research in Health. Ann Martin 28.10.2015 BigData2015 Munsbach, Luxembourg
Enabling Technologies for Collaborative Research in Health Ann Martin 28.10.2015 BigData2015 Munsbach, Luxembourg IMI Europe s partnership for health > 5 bn 2.5 bn Partnership 2008-2024 2.5 bn IMI key
Big data in cancer research : DNA sequencing and personalised medicine
Big in cancer research : DNA sequencing and personalised medicine Philippe Hupé Conférence BIGDATA 04/04/2013 1 - Titre de la présentation - nom du département émetteur et/ ou rédacteur - 00/00/2005 Deciphering
Nanomedicine in Horizon 2020
Nanomedicine in Horizon 2020 Heico FRIMA Programme Officer European Commission Directorate-General for Research & Directorate D: Key Enabling Technologies [email protected] ETPN Annual Event 2014
Energy Efficiency Embedded Service Lifecycle: Towards an Energy Efficient Cloud Computing Architecture
Energy Efficiency Embedded Service Lifecycle: Towards an Energy Efficient Cloud Computing Architecture On behalf of the ASCETiC Consortium Project Number 610874 Instrument Collaborative Project Start Date
Using Ontologies in Proteus for Modeling Data Mining Analysis of Proteomics Experiments
Using Ontologies in Proteus for Modeling Data Mining Analysis of Proteomics Experiments Mario Cannataro, Pietro Hiram Guzzi, Tommaso Mazza, and Pierangelo Veltri University Magna Græcia of Catanzaro, 88100
The Impact of PaaS on Business Transformation
The Impact of PaaS on Business Transformation September 2014 Chris McCarthy Sr. Vice President Information Technology 1 Legacy Technology Silos Opportunities Business units Infrastructure Provisioning
OplAnalyzer: A Toolbox for MALDI-TOF Mass Spectrometry Data Analysis
OplAnalyzer: A Toolbox for MALDI-TOF Mass Spectrometry Data Analysis Thang V. Pham and Connie R. Jimenez OncoProteomics Laboratory, Cancer Center Amsterdam, VU University Medical Center De Boelelaan 1117,
Clinical Research Infrastructure
Clinical Research Infrastructure Enhancing UK s Clinical Research Capabilities & Technologies At least 150m to establish /develop cutting-edge technological infrastructure, UK wide. to bring into practice
Executive Summary for deliverable D7.1: Establish specification for data acquisition and standards used including a concept for local interfaces
Electronic Health Records for Clinical Research Executive Summary for deliverable D7.1: Establish specification for data acquisition and standards used including a concept for local interfaces Project
How Can Institutions Foster OMICS Research While Protecting Patients?
IOM Workshop on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials How Can Institutions Foster OMICS Research While Protecting Patients? E. Albert Reece, MD, PhD, MBA Vice
Human Brain Project -
Human Brain Project - Scientific goals, Organization, Our role Wissenswerte, Bremen 26. Nov 2013 Prof. Sonja Grün Insitute of Neuroscience and Medicine (INM-6) & Institute for Advanced Simulations (IAS-6)
> Semantic Web Use Cases and Case Studies
> Semantic Web Use Cases and Case Studies Case Study: Applied Semantic Knowledgebase for Detection of Patients at Risk of Organ Failure through Immune Rejection Robert Stanley 1, Bruce McManus 2, Raymond
School of Biosciences: MRC Phenome Centre-Birmingham
University of Birmingham College of Life and Environmental Sciences School of Biosciences: MRC Phenome Centre-Birmingham Bioinformatics (Metabolomics-specific) Research Fellow 1 Salary from 28,695 to 37,394
泛 用 蛋 白 質 體 學 之 質 譜 儀 資 料 分 析 平 台 的 建 立 與 應 用 Universal Mass Spectrometry Data Analysis Platform for Quantitative and Qualitative Proteomics
泛 用 蛋 白 質 體 學 之 質 譜 儀 資 料 分 析 平 台 的 建 立 與 應 用 Universal Mass Spectrometry Data Analysis Platform for Quantitative and Qualitative Proteomics 2014 Training Course Wei-Hung Chang ( 張 瑋 宏 ) ABRC, Academia
KNOWLEDGENT WHITE PAPER. Big Data Enabling Better Pharmacovigilance
Big Data Enabling Better Pharmacovigilance INTRODUCTION Biopharmaceutical companies are seeing a surge in the amount of data generated and made available to identify better targets, better design clinical
BBSRC TECHNOLOGY STRATEGY: TECHNOLOGIES NEEDED BY RESEARCH KNOWLEDGE PROVIDERS
BBSRC TECHNOLOGY STRATEGY: TECHNOLOGIES NEEDED BY RESEARCH KNOWLEDGE PROVIDERS 1. The Technology Strategy sets out six areas where technological developments are required to push the frontiers of knowledge
Translational research infrastructure in Neurosciences 15.06.2011/Bruxelles
ITMO Neurosciences, sciences cognitives, neurologie, psychiatrie Translational research infrastructure in Neurosciences 15.06.2011/Bruxelles ITMO Technologie pour la santé 1 NEUROSCIENCE MEDICAL CHALLENGES
Regulatory Issues in Genetic Testing and Targeted Drug Development
Regulatory Issues in Genetic Testing and Targeted Drug Development Janet Woodcock, M.D. Deputy Commissioner for Operations Food and Drug Administration October 12, 2006 Genetic and Genomic Tests are Types
MRMPilot Software: Accelerating MRM Assay Development for Targeted Quantitative Proteomics
MRMPilot Software: Accelerating MRM Assay Development for Targeted Quantitative Proteomics With Unique QTRAP and TripleTOF 5600 System Technology Targeted peptide quantification is a rapidly growing application
ITT Advanced Medical Technologies - A Programmer's Overview
ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,
Increasing the Multiplexing of High Resolution Targeted Peptide Quantification Assays
Increasing the Multiplexing of High Resolution Targeted Peptide Quantification Assays Scheduled MRM HR Workflow on the TripleTOF Systems Jenny Albanese, Christie Hunter AB SCIEX, USA Targeted quantitative
Guidelines for applicants
ERACoSysMed 1st Joint Transnational Call for Proposals for European Research Projects to demonstrate the feasibility and benefits of systems medicine Guidelines for applicants Submission deadline for pre-proposals:
STeP-IN SUMMIT 2013. June 18 21, 2013 at Bangalore, INDIA. Performance Testing of an IAAS Cloud Software (A CloudStack Use Case)
10 th International Conference on Software Testing June 18 21, 2013 at Bangalore, INDIA by Sowmya Krishnan, Senior Software QA Engineer, Citrix Copyright: STeP-IN Forum and Quality Solutions for Information
i2b2 Clinical Research Chart
i2b2 Clinical Research Chart Shawn Murphy MD, Ph.D. Griffin Weber MD, Ph.D. Michael Mendis Vivian Gainer MS Lori Phillips MS Rajesh Kuttan Wensong Pan MS Henry Chueh MD Susanne Churchill Ph.D. John Glaser
From Data to Foresight:
Laura Haas, IBM Fellow IBM Research - Almaden From Data to Foresight: Leveraging Data and Analytics for Materials Research 1 2011 IBM Corporation The road from data to foresight is long? Consumer Reports
Personalized Medicine: Humanity s Ultimate Big Data Challenge. Rob Fassett, MD Chief Medical Informatics Officer Oracle Health Sciences
Personalized Medicine: Humanity s Ultimate Big Data Challenge Rob Fassett, MD Chief Medical Informatics Officer Oracle Health Sciences 2012 Oracle Corporation Proprietary and Confidential 2 3 Humanity
Attacking the Biobank Bottleneck
Attacking the Biobank Bottleneck Professor Jan-Eric Litton BBMRI-ERIC BBMRI-ERIC Big Data meets research biobanking Big data is high-volume, high-velocity and highvariety information assets that demand
Navigating England s clinical research infrastructure. How NOCRI helps simplify access to accelerate discoveries
Navigating England s clinical research infrastructure How NOCRI helps simplify access to accelerate discoveries 2» The National Institute for Health Research (NIHR) Clinical Research Network recruited
Global and Discovery Proteomics Lecture Agenda
Global and Discovery Proteomics Christine A. Jelinek, Ph.D. Johns Hopkins University School of Medicine Department of Pharmacology and Molecular Sciences Middle Atlantic Mass Spectrometry Laboratory Global
Keystones for supporting collaborative research using multiple data sets in the medical and bio-sciences
Keystones for supporting collaborative research using multiple data sets in the medical and bio-sciences David Fergusson Head of Scientific Computing The Francis Crick Institute The Francis Crick Institute
Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning Outcomes
Department/Academic Unit: Pathology and Molecular Medicine Degree Program: PhD Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning
Biotechnology and Life Science Marketing Services Mailing List and Data Card Order Form
C H I Cambridge Healthtech Institute s Biotechnology and Life Science Marketing Services Mailing List and Data Card Order Form Over 800,000 names segmented by scientific interest Featuring U.S and International
2019 Healthcare That Works for All
2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To
Smarter Healthcare@IBM Research. Joseph M. Jasinski, Ph.D. Distinguished Engineer IBM Research
Smarter Healthcare@IBM Research Joseph M. Jasinski, Ph.D. Distinguished Engineer IBM Research Our researchers work on a wide spectrum of topics Basic Science Industry specific innovation Nanotechnology
The M.U.R.D.O.C.K. Study
1 The M.U.R.D.O.C.K. Study Measurement to Understand Reclassification of Disease Of Cabarrus/Kannapolis Jessica Tenenbaum, PhD and many, many others 2 MURDOCK Study Measurement to Understand the Reclassification
University Medical Centres
University Medical Centres in the Netherlands AMC UMC Utrecht University Medical Centres University Medical Centres and the Health System Reform in the Netherlands: a Position Paper In the last ten years
Data mining on the EPIRARE survey data
Deliverable D1.5 Data mining on the EPIRARE survey data A. Coi 1, M. Santoro 2, M. Lipucci 2, A.M. Bianucci 1, F. Bianchi 2 1 Department of Pharmacy, Unit of Research of Bioinformatic and Computational
TRANSLATIONAL BIOINFORMATICS 101
TRANSLATIONAL BIOINFORMATICS 101 JESSICA D. TENENBAUM Department of Bioinformatics and Biostatistics, Duke University Durham, NC 27715 USA [email protected] SUBHA MADHAVAN Innovation Center for
Personalized medicine in China s healthcare system
Personalized medicine in China s healthcare system Jingmin Kan, Sam Linsen Netherlands office for Science and Technology, Guangzhou and Shanghai, China Content PERSONALIZED MEDICINE 2 FOCUS AT THE INDIVIDUAL
Accelerating Development and Approval of Targeted Cancer Therapies
Accelerating Development and Approval of Targeted Cancer Therapies Anna Barker, NCI David Epstein, Novartis Oncology Stephen Friend, Sage Bionetworks Cindy Geoghegan, Patient and Partners David Kessler,
Pharmacology skills for drug discovery. Why is pharmacology important?
skills for drug discovery Why is pharmacology important?, the science underlying the interaction between chemicals and living systems, emerged as a distinct discipline allied to medicine in the mid-19th
The National Institute of Genomic Medicine (INMEGEN) was
Genome is...... the complete set of genetic information contained within all of the chromosomes of an organism. It defines the particular phenotype of an individual. What is Genomics? The study of the
IMPLEMENTING BIG DATA IN TODAY S HEALTH CARE PRAXIS: A CONUNDRUM TO PATIENTS, CAREGIVERS AND OTHER STAKEHOLDERS - WHAT IS THE VALUE AND WHO PAYS
IMPLEMENTING BIG DATA IN TODAY S HEALTH CARE PRAXIS: A CONUNDRUM TO PATIENTS, CAREGIVERS AND OTHER STAKEHOLDERS - WHAT IS THE VALUE AND WHO PAYS 29 OCTOBER 2015 DR. DIRK J. EVERS BACKGROUND TreatmentMAP
ProteinQuest user guide
ProteinQuest user guide 1. Introduction... 3 1.1 With ProteinQuest you can... 3 1.2 ProteinQuest basic version 4 1.3 ProteinQuest extended version... 5 2. ProteinQuest dictionaries... 6 3. Directions for
A Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations
A Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations Ce3, Inc. and Insight Genetics, Inc. Oncology Forum July 15, 2015 Agenda Introductions Definitions Regulations
BIG DATA BREATHES LIFE INTO NEXT-GEN PHARMA R&D
www.wipro.com BIG DATA BREATHES LIFE INTO NEXT-GEN PHARMA R&D Dr.Sarika Vanarse Principal Consultant Pharma R&D, Industry Solutions Group Table of Contents 03... Abstract 03... Introduction 05... Preparing
A Strategy for Plant Breeding Data Management in International Agricultural Research
A Strategy for Plant Breeding Data Management in International Agricultural Research Introduction Exchange of germplasm boosted crop improvement for subsistence agriculture during the 70s and 80s, and
Protein Protein Interaction Networks
Functional Pattern Mining from Genome Scale Protein Protein Interaction Networks Young-Rae Cho, Ph.D. Assistant Professor Department of Computer Science Baylor University it My Definition of Bioinformatics
THE ROLE OF BIG DATA IN HEALTH AND BIOMEDICAL RESEARCH. John Quackenbush Dana-Farber Cancer Institute Harvard School of Public Health
THE ROLE OF BIG DATA IN HEALTH AND BIOMEDICAL RESEARCH John Quackenbush Dana-Farber Cancer Institute Harvard School of Public Health CONFIDENTIAL Background and Disclosures Professor of Biostatistics and
Un (bref) aperçu des méthodes et outils de fouilles et de visualisation de données «omics»
Un (bref) aperçu des méthodes et outils de fouilles et de visualisation de données «omics» Workshop «Protéomique & Maladies rares» 25 th September 2012, Paris [email protected] CEA Grenoble irtsv
Data Management for Biobanks
Data Management for Biobanks JOHANN EDER CLAUS DABRINGER MICHAELA SCHICHO KONRAD STARK University of Klagenfurt and University of Vienna Data Management for Biobanks Local Integration Project Support Anonymization
